Plavix ruling upheld
Executive Summary
U.S. Court of Appeals for the Federal District has upheld the district court ruling that the Plavix (clopidogrel) patent is valid and enforceable, maintaining protection until November 2011 (1"The Pink Sheet" Aug. 4, 2008, p. 19). Sanofi-Aventis and Bristol-Myers Squibb are seeking damages from Apotex, which launched a generic for part of 2006
You may also be interested in...
Generic Plavix Is Expected to Launch in Germany In Mid-August
The two companies with rights to market a generic version of Plavix (clopidogrel) in Germany are mum about their launch date. But Sanofi-Aventis, which markets Plavix with Bristol-Myers Squibb, does not expect to see generic products on the German market before mid-August
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.